• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13D/A filed by Firefly Neuroscience Inc.

    10/23/25 6:39:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology
    Get the next $AIFF alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)


    Firefly Neuroscience, Inc.

    (Name of Issuer)


    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)


    317970101

    (CUSIP Number)


    Jordan Kupinsky
    22 St. Clair Avenue East, Suite 202
    Toronto, A6, M4T 2S3
    (416) 515-2318

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    10/21/2025

    (Date of Event Which Requires Filing of This Statement)


    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    WPC Management Services Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ONTARIO, CANADA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,236,773.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,236,773.00
    11Aggregate amount beneficially owned by each reporting person

    1,236,773.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.2 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 shares of common stock ("Common Shares") of Firefly Neurosciences, Inc. (the "Issuer") held by Windsor Private Capital LP. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    WPC GP I Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ONTARIO, CANADA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,236,773.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,236,773.00
    11Aggregate amount beneficially owned by each reporting person

    1,236,773.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.2 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 Common Shares of the Issuer held by Windsor Private Capital LP. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    Windsor Private Capital LP
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ONTARIO, CANADA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,236,773.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,236,773.00
    11Aggregate amount beneficially owned by each reporting person

    1,236,773.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.2 %
    14Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 Common Shares of the Issuer. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    Jordan Kupinsky
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CANADA (FEDERAL LEVEL)
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,305,533.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,305,533.00
    11Aggregate amount beneficially owned by each reporting person

    1,305,533.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.7 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 Common Shares of the Issuer held by Windsor Private Capital LP, and 68,760 Common Shares held by HJRK Holdings Inc. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    HJRK Holdings Inc.
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    ONTARIO, CANADA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    68,760.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    68,760.00
    11Aggregate amount beneficially owned by each reporting person

    68,760.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    0.5 %
    14Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:
    In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    Rocco Marcello
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,236,773.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,236,773.00
    11Aggregate amount beneficially owned by each reporting person

    1,236,773.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.2 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 Common Shares of the Issuer held by Windsor Private Capital LP. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    CUSIP No.
    317970101


    1 Name of reporting person

    John Cundari
    2Check the appropriate box if a member of a Group (See Instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3SEC use only
    4 Source of funds (See Instructions)

    OO
    5 Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

    Checkbox not checked
    6Citizenship or place of organization

    CANADA (FEDERAL LEVEL)
    Number of Shares Beneficially Owned by Each Reporting Person With:
    7Sole Voting Power

    0.00
    8Shared Voting Power

    1,236,773.00
    9Sole Dispositive Power

    0.00
    10Shared Dispositive Power

    1,236,773.00
    11Aggregate amount beneficially owned by each reporting person

    1,236,773.00
    12Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

    Checkbox not checked
    13Percent of class represented by amount in Row (11)

    9.2 %
    14Type of Reporting Person (See Instructions)

    IN

    Comment for Type of Reporting Person:
    In reference to Rows 8, 10 and 11 above, this amount includes 1,236,773 Common Shares of the Issuer held by Windsor Private Capital LP. In reference to Row 13 above, percentage ownership is based on 13,448,848 Common Shares of the Issuer outstanding as of September 4, 2025.


    SCHEDULE 13D

    Item 1.Security and Issuer
    (a)Title of Class of Securities:

    Common Stock, $0.0001 par value per share
    (b)Name of Issuer:

    Firefly Neuroscience, Inc.
    (c)Address of Issuer's Principal Executive Offices:

    1100 MILITARY ROAD, KENMORE, NEW YORK , 14217.
    Item 1 Comment:
    This Amendment No. 2 (this "Amendment No. 2") to Schedule 13D amends and supplements the Schedule 13D originally filed on August 19, 2024, as amended by Amendment No. 1 thereto filed on October 15, 2025 (the "Schedule 13D"). As used in this Amendment No. 2, the term "Reporting Persons" collectively refers to: WPC Management Services Inc., a corporation formed under the laws of Ontario, Canada ("WPC Management"); WPC GP I Inc., a corporation formed under the laws of Ontario, Canada ("WPC"); Windsor Private Capital LP, a limited partnership formed under the laws of Ontario, Canada ("Windsor"); Jordan Kupinsky, a Canadian citizen ("Mr. Kupinsky"), Managing Partner of Windsor; HJRK Holdings Inc., a corporation formed under the laws of Ontario, Canada ("HJRK"); Rocco Marcello, a Canadian citizen ("Mr. Marcello"), Founder, Chairman and Executive Officer of Windsor; and John Cundari, a Canadian citizen ("Mr. Cundari"), President of Windsor. Information reported in the original Schedule 13D remains in effect except to the extent that it is amended or superseded by information contained in this Amendment No. 2.
    Item 3.Source and Amount of Funds or Other Consideration
     
    The information set forth in Items 4 and 5 is hereby incorporated by reference into Item 3.
    Item 4.Purpose of Transaction
     
    As further described in Item 5(c) below, the Reporting Persons sold an aggregate of 215,928 Common Shares between October 16, 2025 and October 22, 2025. As a result of the transactions described herein, the aggregate percentage of Common Shares that the Reporting Persons may be deemed to beneficially own decreased, as disclosed on the cover pages of this Amendment No. 2.
    Item 5.Interest in Securities of the Issuer
    (a)
    The information relating to the beneficial ownership of the Common Shares by each of the Reporting Persons set forth in Rows 7 through 13 of the cover pages hereto is incorporated by reference herein. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 13,448,848 Common Shares outstanding as of September 4, 2025, as reported in the Issuer's Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 3, 2025.
    (b)
    See (a).
    (c)
    The Reporting Persons effected the following transactions in the open market in the Common Shares on the dates indicated, and such transactions are the only transactions in the Common Shares by the Reporting Persons in the sixty days preceding the filing of this Amendment No. 2, or since the most recent filing of Schedule 13D by the Reporting Persons, whichever is less. Windsor sold 40,139 Common Shares on October 16, 2025 at a price of $2.6522 per Common Share. Windsor sold 45,036 Common Shares on October 17, 2025 at a price of $2.5462 per Common Share. Windsor sold 33,500 Common Shares on October 20, 2025 at a price of $2.4570 per Common Share. Windsor sold 19,222 Common Shares on October 21, 2025 at a price of $2.4004 per Common Share. Windsor sold 78,031 Common Shares on October 22, 2025 at a price of $2.0728 per Common Share.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    WPC Management Services Inc.
     
    Signature:/s/ John Cundari
    Name/Title:John Cundari, Partner
    Date:10/23/2025
     
    WPC GP I Inc.
     
    Signature:/s/ John Cundari
    Name/Title:John Cundari, Partner
    Date:10/23/2025
     
    Windsor Private Capital LP
     
    Signature:/s/ John Cundari
    Name/Title:John Cundari, Partner, WPC GP I Inc., as general partner of Windsor Private Capital LP
    Date:10/23/2025
     
    Jordan Kupinsky
     
    Signature:/s/ JORDAN KUPINSKY
    Name/Title:JORDAN KUPINSKY
    Date:10/23/2025
     
    HJRK Holdings Inc.
     
    Signature:/s/ Jordan Kupinsky
    Name/Title:Jordan Kupinsky, President and Director
    Date:10/23/2025
     
    Rocco Marcello
     
    Signature:/s/ ROCCO MARCELLO
    Name/Title:ROCCO MARCELLO
    Date:10/23/2025
     
    John Cundari
     
    Signature:/s/ JOHN CUNDARI
    Name/Title:JOHN CUNDARI
    Date:10/23/2025
    Get the next $AIFF alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIFF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AIFF
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Firefly Neuroscience Inc.

    SCHEDULE 13D/A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    10/23/25 6:39:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form DEFR14A filed by Firefly Neuroscience Inc.

    DEFR14A - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)

    10/23/25 8:50:18 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Firefly Neuroscience Inc.

    144 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    10/16/25 6:09:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America

    KENMORE, N.Y. and MIAMI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced a new partnership with HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation ("TMS") clinics, and Advanced Behavioral Strategies (ABS). The collaboration comes on the heels of HealingMaps and Capstone Management Group announcing their official launch of the Healing Health Alliance*, the first-of-its-kind Group Purchasing Organization ("GPO"

    9/5/25 7:55:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform

    – Unlocks exciting new AI-driven brain biomarker discovery and advancement capabilities – – Substantial processing speed gains while maintaining high signal quality standards – – Comes just months after Firefly announced its acceptance into the NVIDIA Connect Program – KENMORE, Wash. and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to unveil its new ‘CLEAR' (CLeaning EEG ARtifacts) Platform, a proprietary next-generation preprocessing techno

    8/26/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research

    – Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs – – Collaboration aims to uncover novel insights into the brain's functional architecture in rare genetic conditions – – Building and growing a license business is an increasingly important pillar of Firefly's commercial strategy – KENMORE, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, is pleased to highlight its ongoing collaboration with Prof. Dr. med. Chr

    7/14/25 7:45:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Windsor Private Capital Lp sold $290,185 worth of shares (130,753 units at $2.22) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/22/25 6:36:23 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Large owner Windsor Private Capital Lp sold $269,154 worth of shares (102,675 units at $2.62) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/17/25 8:04:52 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Large owner Windsor Private Capital Lp sold $456,677 worth of shares (166,572 units at $2.74) (SEC Form 4)

    4 - FIREFLY NEUROSCIENCE, INC. (0000803578) (Issuer)

    10/14/25 7:15:01 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Leadership Updates

    Live Leadership Updates

    View All

    Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors

    Quincy, MA, July 10, 2025 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (NASDAQ:SWAG) (NASDAQ:SWAGW), a leading provider of outsourced marketing solutions specializing in promotional products and loyalty incentives, today announced the appointment of Brian M. Posner, MBA, to its Board of Directors. Mr. Posner will serve as Chairman of the Audit Committee. Brian Posner brings over four decades of public company financial leadership, strategic planning, and investor relations experience to the Company. Currently, Mr. Posner serves on the Board of Directors of Firefly Neuroscience, Inc. (NASDAQ:AIFF), where he also chairs the Audit Committee. Firefly is an artificial

    7/10/25 8:00:00 AM ET
    $AIFF
    $SWAG
    Computer Software: Prepackaged Software
    Technology
    Advertising
    Consumer Discretionary

    Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman

    TORONTO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of current director of the Board, Greg Lipschitz, as Executive Chairman, effective as of December 3, 2024. "I look forward to taking on a more active leadership role as Executive Chairman," said Greg Lipschitz, newly appointed Executive Chairman of Firefly. "I believe that Firefly is uniquely positioned at the intersection of artificial intelligence and brain health that I have l

    12/4/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors

    TORONTO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced the appointment of Stella Vnook, Ph.D. to its Board of Directors, effective as of August 19, 2024. Dr. Vnook will serve as Chairperson of the Nominating Committee. Dr. Vnook brings over 25 years of experience as a distinguished pharmaceutical executive, serial entrepreneur, CEO and founder of multiple biotech companies and visionary leader with a track record of success in biotechnology and life

    9/5/24 9:00:00 AM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Financials

    Live finance-specific insights

    View All

    Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update

    Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's dual go-to-market strategy TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," "we," or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders, today announced its financial results for the third quarter ended September 30, 2024, and provided a stockholder update. Firefly is dedicated to improving outcomes for people suffering wi

    11/14/24 5:30:18 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    $AIFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    9/19/24 9:48:56 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:07:51 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Firefly Neuroscience Inc.

    SC 13G - FIREFLY NEUROSCIENCE, INC. (0000803578) (Subject)

    8/21/24 6:03:49 PM ET
    $AIFF
    Computer Software: Prepackaged Software
    Technology